Huddleston HG, Dokras A. Diagnosis and treatment of polycystic ovary syndrome. JAMA. 2022;327(3):274–5.

Article  PubMed  Google Scholar 

Tong C, Wu Y, Zhang L, Yu Y. Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: association with PI3K signaling pathway. Front Endocrinol (Lausanne). 2022;13:1091147.

Article  PubMed  Google Scholar 

Alesi S, Ee C, Moran LJ, Rao V, Mousa A. Nutritional supplements and complementary therapies in polycystic ovary syndrome. Adv Nutr. 2022;13(4):1243–66.

Article  CAS  PubMed  Google Scholar 

Vasey C, McBride J, Penta K. Circadian rhythm dysregulation and restoration: the role of melatonin. Nutrients. 2021;13(10):3480.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boutin JA, Kennaway DJ, Jockers R. Melatonin: facts, extrapolations and clinical trials. Biomolecules. 2023;13(6):943.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ziaei S, Hasani M, Malekahmadi M, Daneshzad E, Kadkhodazadeh K, Heshmati J. Effect of melatonin supplementation on cardiometabolic risk factors, oxidative stress and hormonal profile in PCOS patients: a systematic review and meta-analysis of randomized clinical trials. J Ovarian Res. 2024;17(1):138.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lo Sardo F, Muti P, Blandino G, Strano S. Melatonin and Hippo pathway: is there existing Cross-Talk? Int J Mol Sci. 2017;18(9).

Clark KL, George JW, Przygrodzka E, Plewes MR, Hua G, Wang C, Davis JS. Hippo signaling in the ovary: emerging roles in development, fertility, and disease. Endocr Rev. 2022;43(6):1074–96.

Article  PubMed  PubMed Central  Google Scholar 

Huang Z, Xu T, Liu C, Wu H, Weng L, Cai J, Liang N, Ge H. Correlation between ovarian follicular development and Hippo pathway in polycystic ovary syndrome. J Ovarian Res. 2024;17(1):14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qi MK, Sun TC, Yang LY, He JL, Guo YM, Wang HB, Wang HP. Therapeutic effect of melatonin in premature ovarian insufficiency: Hippo pathway is involved. Oxid Med Cell Longev. 2022;2022:3425877.

Article  PubMed  PubMed Central  Google Scholar 

Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27–36.

Article  CAS  PubMed  Google Scholar 

Siddiqui S, Mateen S, Ahmad R, Moin S. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS). J Assist Reprod Genet. 2022;39(11):2439–73.

Article  PubMed  PubMed Central  Google Scholar 

Teede HJ, Misso ML, Boyle JA, Garad RM, McAllister V, Downes L, et al. Translation and implementation of the Australian-led PCOS guideline: clinical summary and translation resources from the international Evidence-based guideline for the assessment and management of polycystic ovary syndrome. Med J Aust. 2018;209(S7):S3–8.

Article  PubMed  Google Scholar 

Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106(1):6–15.

Article  PubMed  Google Scholar 

Ding H, Zhang J, Zhang F, Zhang S, Chen X, Liang W, et al. Resistance to the insulin and elevated level of Androgen: A major cause of polycystic ovary syndrome. Front Endocrinol (Lausanne). 2021;12:741764.

Article  PubMed  Google Scholar 

Yang J, Chen C. Hormonal changes in PCOS. J Endocrinol. 2024;261(1):e230342.

Article  CAS  PubMed  Google Scholar 

Armanini D, Boscaro M, Bordin L, Sabbadin C. Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism. Int J Mol Sci. 2022;23(8):4110.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pawelczak M, Rosenthal J, Milla S, Liu YH, Shah B. Evaluation of the pro-inflammatory cytokine tumor necrosis factor-α in adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol. 2014;27(6):356–9.

Article  PubMed  PubMed Central  Google Scholar 

Escobar-Morreale HF, Luque-Ramírez M, González F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril. 2011;95(3):1048–58. e1-2.

Article  CAS  PubMed  Google Scholar 

Abraham Gnanadass S, Divakar Prabhu Y, Valsala Gopalakrishnan A. Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update. Arch Gynecol Obstet. 2021;303(3):631–43.

Article  CAS  PubMed  Google Scholar 

Borthakur A, Valsala Gopalakrishnan YDP. Role of IL-6 signalling in polycystic ovarian syndrome associated inflammation. J Reprod Immunol. 2020;141:103155.

Article  CAS  PubMed  Google Scholar 

Sanchez-Garrido MA, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab. 2020;35:100937.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim JJ, Hwang KR, Oh SH, Chae SJ, Yoon SH, Choi YM. Prevalence of insulin resistance in Korean women with polycystic ovary syndrome according to various homeostasis model assessment for insulin resistance cutoff values. Fertil Steril. 2019;112(5):959–e661.

Article  CAS  PubMed  Google Scholar 

Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, Daniali M, Nikfar S, Tsatsakis A, Abdollahi M. Polycystic ovary syndrome: A comprehensive review of pathogenesis, management, and drug repurposing. Int J Mol Sci. 2022;23(2):583.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37(5):467–520.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Glueck CJ, Goldenberg N. Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics. Metabolism. 2019;92:108–20.

Article  CAS  PubMed  Google Scholar 

Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013;6:1–13.

Article  PubMed  PubMed Central  Google Scholar 

Naderpoor N, Shorakae S, de Courten B, Misso ML, Moran LJ, Teede HJ. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Hum Reprod Update. 2015;21(5):560–74.

Article  CAS  PubMed  Google Scholar 

Diamanti-Kandarakis E, Katsikis I, Piperi C, Alexandraki K, Panidis D. Effect of long-term Orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2007;66(1):103–9.

Article  CAS  PubMed  Google Scholar 

van Zuuren EJ, Fedorowicz Z, Carter B, Pandis N. Interventions for hirsutism (excluding laser and photoepilation therapy alone). Cochrane Database Syst Rev. 2015;2015(4):Cd010334.

PubMed  PubMed Central  Google Scholar 

Escobar-Morreale HF, Carmina E, Dewailly D, Gambineri A, Kelestimur F, Moghetti P, et al. Epidemiology, diagnosis and management of hirsutism: a consensus statement by the androgen excess and polycystic ovary syndrome society. Hum Reprod Update. 2012;18(2):146–70.

Article  CAS  PubMed